Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Research In Brief

This article was originally published in The Tan Sheet

Executive Summary

Butterbur vs. Zyrtec: Herbal "should be considered for treating seasonal allergic rhinitis when the sedative effects of antihistamines need to be avoided," Andreas Schapowal, et al., Petasites Study Group, report in Jan. 19 British Medical Journal. In a randomized, double-blind trial, the German and Swiss researchers compared efficacy, tolerability of Petasites hybridus with cetirizine (Pfizer's Zyrtec) in 125 hay fever sufferers for two weeks. Effects of two treatments were comparable, researchers report, adding "butterbur was well tolerated and did not have the sedative effects associated with antihistamines. Fatigue and drowsiness accounted for two-thirds of adverse events reported in the antihistamine group"...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093531

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel